CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
allogeneic hematopoietic stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid...
Phase 3
Saint Louis, Missouri, United States and 23 other locations
of measurable residual disease (MRD) level in patients with acute myeloid leukemia (AML) who have completed induc...
Phase 2
St Louis, Missouri, United States
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
St Louis, Missouri, United States and 88 other locations
This study will be conducted in two parts. Part 1 will be the Dose Confirmation portion to determine recommended Phase 3 dose (RPTD) of venetoclax in...
Phase 3
Saint Louis, Missouri, United States and 160 other locations
This phase 2 study aims to confirm the efficacy seen in the prior phase 1 trial, and further contribute to this effort through the collection of leukemia...
Phase 2
St Louis, Missouri, United States and 2 other locations
and Venetoclax in participants with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndro...
Phase 1
St Louis, Missouri, United States and 14 other locations
). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....
Phase 2
St Louis, Missouri, United States and 32 other locations
GDX012 is a novel cell therapy developed for the treatment of certain types of cancer, including Acute Myeloid Leukemia (A...
Phase 1, Phase 2
St Louis, Missouri, United States and 10 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
St Louis, Missouri, United States and 226 other locations
with cytarabine in patients with relapsed/refractory (r/r) acute myeloid leukemia (AML) or r/r higher-risk myelod...
Phase 1
St Louis, Missouri, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal